Why event-free survival is better than tumor response or other measures of survival as an endpoint in cancer trials.
Dillman
R O
RO
Patty & George Hoag Cancer Center of Hoag Memorial Hospital Presbyterian, Newport Beach, California, USA.
D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D006801:Humans; D009369:Neoplasms / Q000401:mortality* / Q000628:therapy